abstract |
A compound that reduces the activity of a programmed death polypeptide (PD-1) for use in a method of treatment or prevention of persistent viral infection in a subject, wherein said compound is an antibody against PD-L1 and where persistent viral infection It is an infection by the human immunodeficiency virus (HIV). |